Download the mass cytometry app note

Learn how the unique high-content proteomic capabilities of CyTOF™ technology can reveal predictive response, biomarker translation and mechanism of action in cancer immunotherapy clinical trials.

Please complete this form to be directed to a downloadable version of this app note.

It is critical for immunotherapy clinical trials to attain a comprehensive understanding of the immune response to disease and to potential treatment. This in-depth knowledge better enables accurate identification of predictive markers, biomarker translation and understanding mechanism of action, all of which are important for efficient and effective clinical trial execution. CyTOF technology is uniquely positioned to facilitate this level of understanding.